A human neutrophil-dependent pathway for generation of angiotensin II: purification and physicochemical characterization of the plasma protein substrate. 1981

B U Wintroub, and L B Klickstein, and C E Kaempfer, and K F Austen

Human neutrophils contain a neutral protease, previously designated "neutral peptide-generating protease," which generates a smooth muscle contractile activity from a plasma protein substrate. The plasma protein substrate has been purified to homogeneity from fresh citrated human plasma by 45% (wt/vol) ammonium sulfate precipitation of contaminating proteins, Affi-Gel Blue affinity chromatography, hydroxylapatite chromatography, phenyl-Sepharose hydrophobic chromatography, and Sephacryl S-200 gel filtration. The purified product produced a single stained protein on alkaline disc gel electrophoresis and elicited a monospecific goat antiserum. Purification was approximately 330- to 350-fold, and overall recovery was 6-11% of substrate protein in starting plasma as determined by quantitative radial immunodiffusion assay. The substrate has an isoelectric point of pH 4.6-5.1 and is a single polypeptide chain glycoprotein of Mr 62,000-67,000 by sodium dodecyl sulfate electrophoresis. The mean(+/- SD) concentration of this plasma protein substrate in normal serum is 120 +/- 22 microgram/ml. The plasma protein substrate of the neutrophil neutral protease may be identical to human angiotensinogen (renin substrate) because the physicochemical characteristics are similar and the peptide product is recognized by antibody to angiotensin II.

UI MeSH Term Description Entries
D007122 Immunoelectrophoresis A technique that combines protein electrophoresis and double immunodiffusion. In this procedure proteins are first separated by gel electrophoresis (usually agarose), then made visible by immunodiffusion of specific antibodies. A distinct elliptical precipitin arc results for each protein detectable by the antisera.
D009504 Neutrophils Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes. LE Cells,Leukocytes, Polymorphonuclear,Polymorphonuclear Leukocytes,Polymorphonuclear Neutrophils,Neutrophil Band Cells,Band Cell, Neutrophil,Cell, LE,LE Cell,Leukocyte, Polymorphonuclear,Neutrophil,Neutrophil Band Cell,Neutrophil, Polymorphonuclear,Polymorphonuclear Leukocyte,Polymorphonuclear Neutrophil
D010447 Peptide Hydrolases Hydrolases that specifically cleave the peptide bonds found in PROTEINS and PEPTIDES. Examples of sub-subclasses for this group include EXOPEPTIDASES and ENDOPEPTIDASES. Peptidase,Peptidases,Peptide Hydrolase,Protease,Proteases,Proteinase,Proteinases,Proteolytic Enzyme,Proteolytic Enzymes,Esteroproteases,Enzyme, Proteolytic,Hydrolase, Peptide
D001798 Blood Proteins Proteins that are present in blood serum, including SERUM ALBUMIN; BLOOD COAGULATION FACTORS; and many other types of proteins. Blood Protein,Plasma Protein,Plasma Proteins,Serum Protein,Serum Proteins,Protein, Blood,Protein, Plasma,Protein, Serum,Proteins, Blood,Proteins, Plasma,Proteins, Serum
D005779 Immunodiffusion Technique involving the diffusion of antigen or antibody through a semisolid medium, usually agar or agarose gel, with the result being a precipitin reaction. Gel Diffusion Tests,Diffusion Test, Gel,Diffusion Tests, Gel,Gel Diffusion Test,Immunodiffusions,Test, Gel Diffusion,Tests, Gel Diffusion
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine
D013379 Substrate Specificity A characteristic feature of enzyme activity in relation to the kind of substrate on which the enzyme or catalytic molecule reacts. Specificities, Substrate,Specificity, Substrate,Substrate Specificities

Related Publications

B U Wintroub, and L B Klickstein, and C E Kaempfer, and K F Austen
October 1990, Clinical science (London, England : 1979),
B U Wintroub, and L B Klickstein, and C E Kaempfer, and K F Austen
October 1994, Biochimica et biophysica acta,
B U Wintroub, and L B Klickstein, and C E Kaempfer, and K F Austen
October 1976, Biochemistry,
B U Wintroub, and L B Klickstein, and C E Kaempfer, and K F Austen
January 1991, Andrologia,
B U Wintroub, and L B Klickstein, and C E Kaempfer, and K F Austen
October 1992, Clinical science (London, England : 1979),
B U Wintroub, and L B Klickstein, and C E Kaempfer, and K F Austen
June 1995, Biochimica et biophysica acta,
B U Wintroub, and L B Klickstein, and C E Kaempfer, and K F Austen
April 1994, Journal of biochemistry,
B U Wintroub, and L B Klickstein, and C E Kaempfer, and K F Austen
February 1987, Molecular endocrinology (Baltimore, Md.),
B U Wintroub, and L B Klickstein, and C E Kaempfer, and K F Austen
January 1989, Placenta,
Copied contents to your clipboard!